Canary Capital recently submitted an application for an INJ spot ETF to the SEC. After this news broke, INJ surged by 25% in just seven days. Don’t underestimate this—this isn’t just another round of hype; it means the suit-wearing folks on Wall Street have officially set their sights on this public chain that’s specialized for financial scenarios.

If early blockchain projects were like playgrounds littered with LEGO bricks, then Injective 3.0 is more like a precision factory running 24/7. It’s long past the stage of merely shuffling tokens back and forth. What’s running on its assembly line now? Perpetual contracts for pre-IPO company equity, tokenized US Treasury products, and complex financial structures that bring real-world assets on-chain.

**From Niche Language to Mainstream Tool**

The turning point for Injective came last November—it underwent a major upgrade and directly enabled native EVM support.

What does this mean? Previously, if you wanted to develop on this chain, you had to get your hands dirty with CosmWasm, a relatively niche tech stack. Now? Millions of Ethereum developers can jump right in with their familiar tools—MetaMask, Hardhat, Solidity contracts—seamlessly. Once the barrier drops, people flood in.

But the real game-changer is at the underlying architecture. Injective is now built with modular design, no longer that kind of rigid, monolithic system.